Aggressive fibromatosis-associated with papillary thyroid cancer: two cases and a brief review.

Aggressive fibromatosis (AF) is usually considered a benign tumor. Reports of the association between AF and malignancies have appeared infrequently. Herein, we report two cases of AF arising in the neck that were associated with papillary thyroid cancer. Two cases are presented in this article. One is a 31-year-old male patient who was diagnosed with AF 9 months after his thyroid cancer operation; there has been no recurrence after surgical resection and postoperative radiotherapy. The other is a 53-year-old female patient who was diagnosed with thyroid cancer and AF simultaneously. There is still no recurrence after surgical resection, endocrine therapy and thyroid-stimulating hormone (TSH) suppression treatment. Both cases showed β-catenin positivity upon further immunohistochemistry (IHC) examination. AF is a rare and benign tumor. It can occur in association with malignancies, such as thyroid cancer. Whether a patient diagnosed with AF associated with thyroid cancer has a family history of a familial adenomatous polyposis (FAP) mutation or β-catenin mutation should be given more attention. The treatment strategy in this situation includes surgical excision combination with radiotherapy and endocrine therapy to reduce the recurrence rate. 2019 Translational Cancer Research. All rights reserved.

Introduction

Aggressive fibromatosis (AF), also known collectively as desmoid tumors, is a mesenchymal tumor that arises from fascial or deep musculoaponeurotic structures. Although AF lesions do not metastasize, they can be locally invasive and exhibit a propensity to recur despite aggressive surgical resection. This rare tumor has an annual incidence of 2.10 to 5.36 cases per million (1). Approximately 38.6% of desmoid tumors arise in the abdominal region while the most common extra-abdominal sites are reported to be the trunk, extremities, head/neck and other locations (2). AF may occur sporadically or in association with familial adenomatous polyposis (FAP) gene mutations as a component of Gardner’s syndrome. Reports on the association of AF with malignancies have appeared infrequently. Herein, we report two cases of AF arising in the neck associated with papillary thyroid cancer.

Case presentation

Case 1

A 31-year-old male patient had been diagnosed with a left papillary micro-thyroid carcinoma () with node metastases and received a total thyroidectomy with bilateral central neck dissection and left lateral neck dissection in January 2014 in our hospital. After the operation, he received radioiodine treatment and thyroid-stimulating hormone (TSH) suppression treatment with levothyroxine. In September 2014, an ultrasound (US) review showed a heterogeneous hypoechoic lump located in his left neck, between the level III and V lymph node compartments, measuring 58 mm × 20 mm × 30 mm (). Pathologic results of fine-needle aspiration cytology (FNAC) from the lump suggested a spindle cell tumor diagnosis with AF tendencies. When the lump increased gradually to the size of 62 mm × 41 mm × 46 mm (), the patient came to our hospital again in July 2015 and received a secondary operation. Extensive resection was performed on his left neck under general anesthesia in August 2015. AF in his left neck was confirmed by postoperative pathologic examination (). Further immunohistochemistry (IHC) examination showed that the mass was smooth muscle actin (SMA) negative, β-catenin positive, CD34 positive and Desmin negative. After discharge, he received adjuvant radiotherapy, and no recurrence has occurred to date.

Figure 1

The pathologic image of Case 1—PTC. Hematoxylin-eosin staining, 20×. PTC, papillary thyroid carcinoma.

Figure 2

US image of Case 1—AF in September 2014. A heterogeneous hypoechoic lump located in the left neck, between level III and V lymph node compartment, measuring 58 mm × 20 mm × 30 mm. US, ultrasound; AF, aggressive fibromatosis.

Figure 3

US image of Case 1—AF in July 2015. The lump located in the left neck had increased, measuring 62 mm × 41 mm × 46 mm. US, ultrasound; AF, aggressive fibromatosis.

Figure 4

The pathologic image of Case 1—AF. Hematoxylin-eosin staining, 10×. AF, aggressive fibromatosis.

Case 2

A 53-year-old female patient who presented with a palpable lump in the posterior triangle of her left neck, came to our hospital in October 2014. High-resolution-US showed a heterogeneous hypoechoic lump located in her left level V lymph node compartment, measuring 50 mm × 17 mm (). Preoperative sonography detected another hypoechoic nodule with irregular margins in her left thyroid region. The size was approximately 7 mm × 9 mm (). Physical examination and US did not find any suspicious enlarged lymph nodes in her neck. FNAC biopsy suggested that a papillary thyroid carcinoma (PTC) and spindle cell tumor were separately rendered on her left thyroid nodule and the lump in her left level V compartment. The oral administration of tamoxifen (10 mg, twice a day) for one week before surgery had no effect on the lump; then, the patient received a total thyroidectomy with bilateral central neck dissection and left lateral neck dissection. The final pathologic findings confirmed AF concomitant with left PTC without any neck lymph node metastasis (). Further IHC results showed that the mass was SMA positive, caldesmon positive, CD34 positive, β-catenin nuclear staining positive and desmin negative. The patient received TSH suppression treatment with levothyroxine after discharge from our hospital and no recurrence has been observed to date.

Figure 5

US image of Case 2—a lump. A heterogeneous hypoechoic lump was located in the left level V lymph node compartment, measuring 50 mm × 17 mm. US, ultrasound.

Figure 6

US image of Case 2—a nodule. Another hypoechoic nodule with irregular margins in the patient’s left thyroid region, measuring 7 mm × 9 mm. US, ultrasound.

Figure 7

The pathologic image of Case 2—PTC. Hematoxylin-eosin staining, 10×. PTC, papillary thyroid carcinoma.

Figure 8

The pathologic image of Case 2—AF. Hematoxylin-eosin staining, 10×. AF, aggressive fibromatosis.

Discussion and conclusions

AF tumors are pathologically benign tumors that never metastasize, and they are notorious for their locally aggressive growth and recurrence; lesions may invade surrounding muscles, blood vessels and nerves (3). Although the etiology of AF is not fully understood, several factors, such as hormone status, e.g., estrogen, genetic predisposition, e.g., the FAP gene, and prior local invasion, e.g., surgery or trauma, have been implicated (4). The treatment strategy for AF includes surgical excision and in combination radiotherapy, chemotherapy and endocrine therapy to reduce the recurrence (5). Case 1 is a young patient with more extensive margins and a higher risk of recurrence, so he has accepted postoperative radiotherapy, and no recurrence has occurred so far. While there is still controversy over the effect of chemotherapy on AF and no recommended protocol, the two cases in this report did not accept chemotherapy. For Case 2, there was no effect after the continuous use of tamoxifen treatment for one week, postmenopausal status and short term endocrine therapy may be possible reasons.

AF usually occurs sporadically, and there are few reports of the association between AF with maligna ncies. Here, we conducted a review of the previously published cases of AF associated with malignancies in the English literature (). In most cases, AF occurred after a malignant tumor operation; AF occurred together with malignancies in only one case in the literature and in Case 2 in this report. Surgical trauma may be the main reason for AF in these cases. In fact, there have been few cases of AF reportedly mimicking lymph node metastasis after a malignant tumor operation according to the location or imaging examination, so it is necessary to conduct a preoperative FNAC biopsy for differential diagnosis. The cribriform-morular variant of papillary thyroid carcinoma (CMV-PTC), a very unusual subtype with better prognosis, is commonly seen in association with FAP (6). AF can also occur in association with the FAP gene mutation as a component of Gardner’s syndrome (7), while in the present study, neither of the two patients had a family history of FAP or pathologic features of CMV-PTC.

Table 1

A review of AF associated with malignancies in the English literature.

Case	Report	PMID	Year	AF location	Associated with malignant tumors	Surgical pattern	Pre/post operation	Recurrence (interval/month)
1	Dale et al.	8579271	1995	Chest wall	Breast cancer	Alloplastic breast reconstruction	After	No report
2	Hyodoet al.	11172213	2001	Neck and inguinal region	Gastric scirrhous carcinoma	No surgery	Simultaneously	Death
3	Khanfiret al.	12775750	2003	Chest wall	Breast cancer	Radical mastectomy and immediate reconstruction	After	No report
4	Komatsu et al.	16824087	2006	Intra-abdominal	Gastric cancer	Gastrectomy	After	No recurrence/9 m
5	Xu et al.	21459731	2011	Intra-abdominal	Cholangiocarcinoma	Pancreaticoduodenectomy	After	No recurrence/6 m
6	Cha W et al.	24115367	2014	Left anterior neck	Papillary thyroid microcarcinoma	Transaxillary robotic right thyroidectomy	After	No recurrence/6 m
7	Tomita et al.	24743485	2014	Chest	Lung adenocarcinoma	Right upper lobectomy	After	No recurrence/60 m
8	Shinohara et al.	27474466	2016	Larynx	Squamous cell carcinoma	Laryngo-microsurgery	After	No recurrence/60 m

AF, aggressive fibromatosis.

Recent studies demonstrated a relatively high frequency of β-catenin heterozygous mutations in AF, and these mutations lead to posttranslational stabilization of the β-catenin protein, which plays a key role in the Wnt signaling pathway (8). Recent original studies indicate that AF is related to the 41 or 45 site mutation on exon 3 in the CTNNB1 gene on 3p21, resulting in β-catenin overexpression in nuclei by ICH detection (9). Therefore, β-catenin positivity in IHC is often used for the differential diagnosis of AF. In these two cases, β-catenin positivity on IHC staining was consistent with the reported results.

In addition, papillary thyroid cancer with nodular fasciitis-like stroma is another subtype of papillary thyroid cancer according to the pathological features (10). It is a dual tumor comprising malignant epithelial proliferation and prominent mesenchymal proliferation resembling nodular fasciitis or fibromatosis, and IHC results have shown that the β-catenin staining is positive. One report proposed that PTC with nodular fasciitis-like stroma and β-catenin mutations should be renamed PTC with desmoid-type fibromatosis (11). Thus, there may be a relationship between AF and PTC with desmoid-type fibromatosis on the basis of the same pathological features and β-catenin mutation. With the acquisition of more data, further investigation may yield molecular determinants.

In summary, AF is a rare and benign but locally infiltrating and progressive tumor. AF can occur in association with malignancies, such as thyroid cancer. Whether a patient diagnosed with AF associated with thyroid cancer has a family history of FAP, FAP mutation, or β-catenin mutation should begiven more attention. The treatment strategy in this situation includes surgical excision and combination with radiotherapy and endocrine therapy to reduce the recurrence rate.